DCM
XERS icon

Driehaus Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Driehaus Capital Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-902,740
Closed -$5.24M – 431
2026
Q1 		$5.24M Sell
902,740
-2,077,827
-70% -$13.8M 0.04% 289
2025
Q4 		$23.4M Buy
2,980,567
+361,438
+14% +$2.84M 0.16% 183
2025
Q3 		$21.3M Buy
2,619,129
+548,054
+26% +$3.64M 0.15% 195
2025
Q2 		$9.67M Buy
2,071,075
+659,535
+47% +$3.02M 0.08% 259
2025
Q1 		$7.75M Buy
1,411,540
+817,525
+138% +$3.3M 0.07% 272
2024
Q4 		$2.01M Buy
+594,015
New +$1.91M 0.02% 311

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Driehaus Capital Management's XERS Position: Q2 2026 in Review

Driehaus Capital Management sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 902,740 shares — an estimated $5.24M sold.

Driehaus Capital Management first reported a position in XERS in Q4 2024 and held it in 6 quarters. The position peaked at $23.4M in Q4 2025. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Driehaus Capital Management reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • Driehaus Capital Management sold 902,740 Xeris Biopharma Holdings shares in Q2 2026, an estimated $5.24M.
  • Driehaus Capital Management first reported a position in Xeris Biopharma Holdings in Q4 2024 and held it in 6 quarters.
  • Driehaus Capital Management's Xeris Biopharma Holdings position peaked at $23.4M in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.